# Cannabis & Politics: A Nation in Motion as Federal Rescheduling Reshapes State-Level Reform
Federal rescheduling is reshaping cannabis politics from coast to coast, and the reverberations are unmistakable. President Trump's push to reclassify marijuana from Schedule I is opening doors that have been locked for decades — particularly in conservative-leaning states where federal classification was the last political cover needed to resist legalization. According to [Marijuana Moment](https://www.marijuanamoment.net/top-gop-tennessee-lawmaker-says-federal-marijuana-rescheduling-could-open-door-to-legalizing-medical-use-in-his-state/), Tennessee's House Majority Leader William Lamberth (R) has signaled that rescheduling could finally unlock medical marijuana legalization in his state, calling it a resolution to his "biggest objections." The Georgia House just passed a bill to modernize its medical cannabis program with broad bipartisan support, while simultaneously Georgia lawmakers filed a resolution urging Congress to reschedule marijuana to Schedule III. 🚀 THIS IS COOL Minnesota lawmakers approved psilocybin therapy legalization while rescheduling the psychedelic under state law — a genuine breakthrough in psychedelic medicine access. These aren't isolated incidents; they're part of a coordinated shift where federal movement is giving political cover to state-level reformers who previously claimed their hands were tied.
But not every state is moving at the same speed, and the political resistance remains fierce in some places. [Marijuana Moment](https://www.marijuanamoment.net/florida-supreme-court-rejects-marijuana-campaigns-appeal-to-restore-legalization-ballot-signatures-effectively-ending-2026-push/) reports that Florida's Supreme Court rejected a legalization campaign's bid to restore ballot signatures, effectively killing the 2026 push for recreational cannabis in the state — a devastating blow to reformers in a state with nearly 22 million residents. Meanwhile, Oklahoma's governor is claiming lawmakers support his push to roll back the state's voter-approved medical marijuana program, despite recent skepticism from GOP leaders including Senate President Pro Tempore Lonnie Paxton, who acknowledged it would be "really hard to completely undo" legalization and unfair to operators who "invested their life savings into this program." Tennessee, by contrast, is relaunching its "Pot for Potholes" campaign to legalize recreational cannabis and use tax revenue for infrastructure — a fresh narrative that ties cannabis legalization directly to tangible public goods. Virginia just sent a bill to Governor Spanberger's desk to legalize recreational marijuana sales, inching the nation closer to a genuinely post-prohibition moment on the East Coast.
The barriers to ballot access are becoming as much a political issue as cannabis itself. According to [The Pacific Northwest Inlander](https://www.inlander.com/news/idaho-voters-would-likely-pass-abortion-rights-and-medical-marijuana-but-lawmakers-have-intentionally-made-article_9aaf9533-1aad-4d9d-8dae-2677a21894eb.html), Idaho voters would likely pass medical marijuana legalization — polls show clear support — but conservative legislators have deliberately made the initiative process harder through geographic-based distribution requirements that force signature collection across multiple legislative districts. New Hampshire's House, meanwhile, let marijuana legalization and psilocybin therapy bills die without floor votes, effectively killing them before the public even got a say. 🎭 DOUBLE STANDARD WATCH When some states make ballot access so difficult that popular policies never reach voters, while other states embrace direct democracy, we're not really talking about majority rule anymore — we're talking about structural power imbalances that have nothing to do with cannabis policy and everything to do with who gets to vote.
💰 MONEY MOVES Federal tax policy remains a stranglehold on the cannabis industry despite growing legalization momentum. The IRS is fighting cannabis businesses' arguments that federal rescheduling should exempt them from Section 280E tax code, which bars cannabis businesses from deducting ordinary business expenses — a burden that doesn't apply to alcohol, tobacco, or pharmaceutical companies. An analysis by [Marijuana Moment](https://www.marijuanamoment.net/marijuana-rescheduling-is-a-transitional-step-that-must-be-followed-by-banking-commerce-and-justice-reforms-new-analysis-says/) found that rescheduling alone is merely a "transitional" step; comprehensive banking, commerce, and justice reforms must follow to align state and federal law while promoting equity. Meanwhile, Senator Jeff Merkley (D-OR) filed an amendment to a housing bill that would let cannabis industry workers qualify for federally backed mortgage loans by treating cannabis income the same as other industries. Without these systemic fixes, legalization remains economically crippled — cannabis businesses operate in a federal legal gray zone where they can't access normal banking, can't deduct standard business expenses, and face workforce challenges that legal industries never encounter.
Psychedelics are riding the normalization wave alongside cannabis. [Marijuana Moment](https://www.marijuanamoment.net/hawaii-senate-passes-bill-to-create-psychedelics-task-force-and-study-pathways-to-access-psilocybin-and-mdma/) reports Hawaii's Senate passed a bill to create a psychedelics task force and study access to breakthrough therapies like psilocybin and MDMA. A new study published by the American Medical Association found that psilocybin combined with cognitive behavioral therapy yielded significantly greater results for smoking cessation than therapy alone. Colorado is pushing a bipartisan ibogaine research pilot program to study this powerful plant medicine's ability to "reset" the brain and combat addiction. The Supreme Court is hearing oral arguments Monday on whether marijuana users can legally own firearms — an unusual case that's united the NRA and ACLU against the Trump administration and gun-control groups, all because federal cannabis prohibition creates a vague and potentially unconstitutional barrier to Second Amendment rights. 🚀 THIS IS COOL This coalition itself is a sign of how cannabis has moved beyond the left-right political spectrum; when gun rights advocates and civil liberties unions are on the same side, prohibition's political foundation is crumbling.
Some states are taking a harder line on cannabis derivatives and intoxicating hemp products, creating a fragmented landscape. Texas just banned intoxicating hemp flower effective March 31, while Ohio's Governor DeWine is threatening to eliminate hemp beverages entirely — a veto that's already been challenged in the state Supreme Court and is sparking lawsuits from breweries. 🤔 THINK ABOUT IT If hemp and cannabis products are legal in one state and banned in the next, what does that tell us about the scientific basis for prohibition versus the political basis? A [Columbia University study](https://medicalxpress.com/news/2026-03-recreational-cannabis-laws-displace-illegal.html) found that adopting recreational cannabis laws beyond medical programs helps reduce illegal cannabis markets in states — yet some governors are moving in the opposite direction, creating conditions where unlicensed markets thrive and consumers turn to unregulated sources. Meanwhile, the 9th Circuit Court just ruled that the Dormant Commerce Clause doesn't apply to cannabis markets, sparking a circuit split that could reshape how states regulate cross-border cannabis commerce. Arizona passed a bill allowing jail time for creating "excessive" marijuana smoke or odor — a policy that will affect both recreational users and medical patients in their own homes. These state-by-state contradictions are exactly what nationwide decriminalization and rescheduling could simplify, but we're not there yet. The question for readers: as more states legalize cannabis for medical and recreational use, how much longer can we justify a patchwork system where neighbors in different states face completely different legal consequences for the same plant?
# Hemp Ban Watch: A Nation Fractured on THC as Texas Pulls the Trigger
Texas is about to become ground zero for what happens when a state decides smokable hemp has to go. Effective March 31—that's in just over two weeks—the Texas Department of State Health Services has finalized rules that will effectively ban intoxicating hemp flower statewide, rewriting how the state measures THC content in ways that industry advocates say will cripple a market worth $5.5 billion to $12 billion annually. The shift is simple on paper but devastating in practice: instead of testing products for delta-9 THC content alone (the threshold that's been 0.3% since the 2018 Farm Bill), Texas will now measure "total THC," which includes THCA—a non-psychoactive compound that converts to delta-9 when heated. 💰 MONEY MOVES Mark Bordas, executive director of the Texas Hemp Business Council, warned bluntly: "You're talking about shuttering stores that employ over 50,000 Texans. You're talking about major market disruption to an industry that generates over $10-12 billion a year." According to analysis from the Texas Cannabis Policy Center, this move will hand roughly 50 percent of the legal market directly to illicit operators—the exact opposite of what regulators claim they want.
What makes this story darker is the admission from hemp store operators themselves about what's coming. Nicholas Mortillaro, who runs a hemp retail operation, told reporters the ban will trigger "60-70% declines" in sales within three weeks, since smokable hemp is the most commonly ordered product across Texas shops. One anonymous retailer put it even more starkly: "For many small retailers across Texas—including my own vape shop—these rules will effectively shut down our businesses overnight." These aren't corporate chains crying foul; these are small business owners who built legitimate enterprises on products that were legal last month and will be illegal next month. The state did sweeten the pill slightly by lowering licensing fees—retail licenses dropped from a proposed $20,000 to $5,000 annually, and manufacturer fees fell from $25,000 to $10,000—but for businesses that lose 70 percent of their revenue stream, a lower licensing fee is like offering an aspirin to someone having a heart attack.
What's wild is that Texas lawmakers actually had a chance to stop this. During the 2025 legislative session, [according to Marijuana Moment](https://www.marijuanamoment.net/texas-officials-unveil-amended-hemp-rules-with-strict-total-thc-limits-but-lower-licensing-fee-than-previously-floated/), Senate Bill 3 would have banned hemp-derived THC products outright—a total scorched-earth approach. Governor Greg Abbott vetoed that bill in June, but then took a different route: he issued an executive order asking state agencies to "revise testing requirements" to measure total THC instead of delta-9 alone. The Department of State Health Services answered that call with these new rules. So technically, the governor blocked a legislative ban, but then used executive power to accomplish nearly the same goal through regulatory sleight of hand. The public comment period generated over 1,400 responses urging revisions, and the industry screamed loud enough to lower some fees—but the total THC standard stayed locked in. 🎭 DOUBLE STANDARD WATCH A plant that has never caused a recorded overdose death is being systematically removed from shelves, while alcohol—which kills roughly 95,000 Americans per year—remains the most heavily advertised consumer product in America. Something doesn't add up.
But Texas isn't alone. A wave of hemp restrictions is rolling across the nation, and the patterns are starting to look like a coordinated reckoning. In Ohio, as [the Columbus Dispatch](https://www.msn.com/en-us/news/us/small-businesses-prepare-for-ohios-hemp-ban-were-the-ones-who-suffer/ar-AA1Yu5t9) reported, CBD stores and breweries are bracing for a ban on hemp and THC drinks. South Carolina lawmakers are actively debating whether to regulate hemp-derived THC products like alcohol, with [the State House taking up the question](https://www.southcarolinapublicradio.org/sc-news/2026-03-12/the-state-house-gavel-gov-vetoes-nil-bill-senate-rejects-total-ban-of-consumable-hemp-products). North Carolina shop owners [fear a "total collapse"](https://www.msn.com/en-us/health/other/nc-hemp-shop-owners-fear-total-collapse-of-industry-under-new-federal-law/ar-AA1YsUoz) under new federal hemp rules set to take effect in November. Alabama introduced a bill to ban all psychoactive cannabinoids. Maryland locked THC products out of gas stations. Even Kansas businesses are suing the state's attorney general over raids on products they claim are legal. It's a patchwork of prohibition wearing a regulatory disguise, and small business owners are the ones getting caught in the crossfire.
There's a genuinely concerning ripple effect happening here that nobody's talking about loudly enough: veterans and medical patients who've been using legal THC products for legitimate health reasons—PTSD, chronic pain, anxiety, sleep disorders—are about to lose access or be pushed toward unregulated markets. When you ban the legal product, you don't eliminate demand; you just hand it to sellers with zero testing standards, no quality control, and no accountability. Heather Fazio from the Texas Cannabis Policy Center nailed this: "Consumers enjoy the natural product with naturally occurring levels of THC in the hemp flower, and changing to these unreasonably restrictive testing standards would push this marketplace underground, handing it over to illicit operators because legitimate businesses can no longer sell it. That means that products are going to be untested." Meanwhile, [according to Medical Xpress](https://medicalxpress.com/news/2026-03-inconsistent-high-doses-delta-8-thc.html), delta-8 THC products in unregulated markets already show "inconsistent labeling and high doses," often coming in youth-oriented packaging. So the stated goal of "protecting consumers" achieves the opposite: it eliminates the regulated, labeled, age-gated products in favor of whatever the black market brings.
On the brighter side, there's at least one state swimming against this current. [According to Marijuana Moment](https://www.marijuanamoment.net/virginia-lawmakers-reach-deal-on-final-bill-to-legalize-recreational-marijuana-sales/), Virginia's legislature just passed a bill legalizing recreational marijuana sales and sent it to Governor Abigail Spanberger's desk, with both chambers agreeing on a January 1, 2027 launch date for adult-use retail. The compromise included a 6 percent excise tax plus local option taxes up to 3.5 percent—a framework that actually trusts adults and creates a regulated market instead of destroying one. It's proof that a different path exists, but it requires political will that most conservative legislatures simply don't have. 🤔 THINK ABOUT IT Texas is about to eliminate 50,000 jobs and hand billions in sales to the black market in the name of "safety," while Virginia is building a legal, tested, tax-generating marketplace. Both states had choices. Which one is actually protecting consumers?
Research showing THC disrupts memory formation is raising new questions about how cannabis affects the brain—even as scientists simultaneously discover the plant's compound could reverse liver disease affecting one-third of adults. A study from Washington State University published in the Journal of Psychopharmacology found that people who consumed THC were significantly more likely to recall words that were never shown to them and struggled with everyday memory tasks like remembering appointments. 🚀 THIS IS COOL The research was notably comprehensive, examining seven different types of memory at once rather than just one or two, and surprisingly found that even moderate doses of 20 milligrams caused memory problems similar to higher doses of 40 milligrams. Yet in the same news cycle, researchers at Hebrew University of Jerusalem reported that cannabidiol (CBD) and cannabigerol (CBG)—the non-psychoactive compounds in cannabis—could significantly reduce liver fat and improve metabolic health in metabolic dysfunction-associated steatotic liver disease (MASLD), a condition affecting roughly one-third of the global adult population.
The disconnect matters because it reveals how cannabis science is genuinely complex: the plant isn't a monolith. THC and CBD do very different things in the body, and understanding those differences is exactly what policy should be based on. Meanwhile, over 70 cannabis-related studies published so far in 2026 are exploring everything from pain relief and cancer to brain injury and sleep—underscoring just how broad the therapeutic field has become. Yet policy hasn't caught up with the science. 💰 MONEY MOVES Medicare is expected to begin a pilot program as early as April 2026 providing seniors with up to $500 annually to purchase CBD products, while a new study published in the Journal of Pain Research found that CBD-dominant full-spectrum marijuana extracts were associated with stronger pain relief and fewer side effects than pure THC in older adults with chronic pain—with 85.7% of patients using CBD-dominant extracts meeting the primary treatment benchmark compared to just 21.9% using pure THC.
The gender dimension of medical cannabis is shifting too. Women are actively reshaping the cannabis market by pushing for products that address gaps in women's health, from endometriosis and pelvic pain to sexual dysfunction. 🚀 THIS IS COOL A study led by the University of Otago, Wellington showed that medicinal cannabis reduced pain, improved sleep, and lowered anxiety in endometriosis patients—a condition that affects roughly 10% of women of reproductive age and for which treatment options remain limited. At the same time, cannabis may help women's sexual health in ways that weren't on the scientific radar until recently: a growing body of literature suggests cannabis could hold significant therapeutic potential in treating female orgasmic disorder, positioning it as a "gateway to women's orgasm" rather than the prohibitionist nightmare of decades past.
But there's a darker side to the expanding cannabis market that deserves attention. Medical Xpress reported that delta-8 THC products—marketed as "legal" cannabis—have spiked in popularity despite inconsistent labeling and doses that often exceed what's advertised. These products come in youth-oriented packaging, raising genuine questions about access and safety in an unregulated space. 🎭 DOUBLE STANDARD WATCH Cannabis remains Schedule I while alcohol—responsible for 95,000 deaths per year—is advertised during every major sporting event. Cannabis kills zero. Why is one a controlled substance and the other in every grocery store? Similarly, a new study found that people using cannabis had a higher stroke risk, particularly when smoked, reminding us that method of consumption matters enormously and that public health messaging should distinguish between smoking, vaping, and ingesting. This is the kind of nuance that gets lost when a plant is Schedule I and the government refuses to fund meaningful research into harm reduction.
Veterans are becoming a critical constituency in the normalization conversation. Bipartisan senators including Ruben Gallego (D-AZ) and David McCormick (R-PA) introduced the "Innovative Therapies Centers of Excellence Act," which would establish at least five VA research centers to study psychedelics like psilocybin, MDMA, and DMT for PTSD, depression, and other conditions affecting veterans. Meanwhile, a large Department of Veterans Affairs study found that GLP-1 drugs like semaglutide were associated with reduced substance use disorder risk across every major addictive substance in veterans—suggesting that multiple pathways to healing exist and should all be explored. The point: when veterans have access to both plant-based and pharmaceutical options, outcomes improve.
🤔 THINK ABOUT IT We're in a moment where the science is racing ahead of policy. Over 70 peer-reviewed studies on cannabis and cannabinoids are being published in 2026 alone. Medicare is about to cover CBD for seniors. Multiple states are modernizing access laws. Yet federal policy still classifies cannabis as Schedule I—meaning it has no accepted medical use—while the evidence for medical use keeps piling up. The conversation is shifting from "should we study this?" to "why are we still fighting about it?" That's progress. But it's also incomplete as long as people remain incarcerated for something that now helps seniors with chronic pain, veterans with PTSD, and women with endometriosis in neighboring states where it's legal. The science says one thing. The law says another. At what point do they have to meet?
Texas Bans Smokable Hemp Products in Two Weeks, Threatening Thousands of Jobs and Pushing Consumers Toward Black Markets
Starting March 31, Texas will effectively ban virtually all smokable hemp products—a move that advocates say will shutter thousands of small businesses, eliminate roughly 50,000 jobs, and hand a multibillion-dollar market straight to illicit operators. The Texas Department of State Health Services finalized new regulations this month that change how the state measures THC in hemp products, shifting from testing for Delta-9 THC alone to a "total THC" calculation that includes THCA, a non-psychoactive compound that converts to Delta-9 when heated or smoked. This single regulatory change makes most hemp flower sold in Texas today instantly illegal—even though it's been completely legal under federal and state law since 2019. 💰 MONEY MOVES The hemp industry generates between $5.5 billion and $12 billion annually in Texas, according to [Marijuana Moment](https://www.marijuanamoment.net/texas-officials-unveil-amended-hemp-rules-with-strict-total-thc-limits-but-lower-licensing-fees-than-previously-floated/), and retailers like those profiled by the [Dallas Observer](https://www.dallasobserver.com/news/dallas-thc-businesses-react-to-impending-smokable-hemp-ban-40653083/) are bracing for 60–70% revenue declines. Some owners say they'll close entirely.
The new rules did make one concession: licensing fees are lower than originally proposed. Retail locations will pay $5,000 annually instead of the initially floated $20,000, and manufacturers face $10,000 annual fees instead of $25,000—changes [advocates called "a direct victory,"](https://www.marijuanamoment.net/texas-officials-unveil-amended-hemp-rules-with-strict-total-thc-limits-but-lower-licensing-fees-than-previously-floated/) according to Heather Fazio, director of the Texas Cannabis Policy Center. But even these reduced fees represent massive hikes from the current $150 retail fee and $250 manufacturer fee. Edibles and infused beverages remain legal, though they'll face stricter testing and labeling requirements. Still, as [Houston Public Media](https://www.houstonpublicmedia.org/articles/news/business/2026/03/11/545801/austin-tx-texas-marijuana-hemp-ban-selling-smokable-cannabis-thc/) reported, smokable products are the most popular segment—meaning most retailers will lose their core revenue stream regardless of the fee reductions.
How did we get here? Governor Greg Abbott vetoed a bill last summer that would have banned hemp-derived THC outright, but he didn't protect the market—he punted it to regulators. Abbott issued an executive order directing state agencies to impose stricter rules, and the Department of State Health Services responded by redefining how THC gets measured. The agency received over 1,400 public comments urging them to exclude THCA from the total THC calculation, noting that THCA itself is not psychoactive and isn't explicitly banned by state or federal law. The USDA and Texas Agriculture Commission do have regulations accounting for THCA conversion, but those were written for farm-level hemp testing to distinguish agricultural hemp from cannabis grown for intoxication—not to ban legal products already on store shelves. 🎭 DOUBLE STANDARD WATCH Cannabis remains Schedule I while alcohol—responsible for roughly 95,000 deaths per year in America—is sold in every convenience store and advertised during prime-time TV. So why is a plant with zero recorded overdose deaths in human history being regulated out of existence, while the substance killing tens of thousands annually faces no such restrictions?
Attorneys representing hemp retailers are already warning of ripple effects beyond job losses. [Marijuana Moment](https://www.marijuanamoment.net/texas-could-see-a-spike-in-raids-on-hemp-businesses-under-new-rules-industry-advocates-fear/) reports that hemp business lawyers fear the new licensing structure and enforcement costs will trigger an uptick in police raids on retailers. Since August 2024, law enforcement has raided more than 15 hemp businesses across Texas, seizing cash and inventory that businesses haven't recovered—and many raids have concluded without criminal charges filed. As [The Texas Tribune](https://www.msn.com/en-us/news/us/texas-hemp-businesses-fear-an-uptick-in-police-raids-after-more-than-15-in-the-last-two-years/ar-AA1XOHps) documented, retailers have paid compliance attorneys "phenomenal" amounts to stay legal, only to face raids that destroy their reputation and freeze their assets. Expect that pattern to accelerate once the ban takes effect.
Here's what nobody's talking about openly: pushing 50,000 jobs underground and removing 50 percent of a legal market doesn't eliminate demand. It redirects it. 🤔 THINK ABOUT IT If Texas lawmakers genuinely believe that smokable hemp products pose a public safety risk, shouldn't they worry that banning the regulated, tested version will drive consumers to unregulated suppliers where there's zero oversight of what's actually in the product? Meanwhile, Texas is quietly expanding its medical cannabis program—with nine new licenses already approved and three more coming before April 1, according to [Marijuana Moment](https://www.marijuanamoment.net/texas-officials-approve-nine-new-medical-marijuana-business-licenses-as-state-expands-patient-access/). So the state is saying: smokable hemp flowers are too dangerous for adults to buy legally in a shop, but medical cannabis is the future. That's not consistency—that's a roadmap written by people who never decided what they actually think cannabis is.
The clock is ticking. In less than two weeks, thousands of products will vanish from Texas shelves, thousands of workers will lose jobs, and a multibillion-dollar legal market will transfer to black-market operators. The state collected over 1,400 comments begging regulators to reconsider. They ignored nearly all of them. 🚀 THIS IS COOL At least Texas's medical marijuana program is expanding—proving that even in one of America's most conservative states, cannabis normalization is happening. But until the state gets honest about why a zero-overdose plant deserves Schedule I treatment while alcohol kills nearly 100,000 Americans yearly, these regulations will keep looking less like public health policy and more like prohibition dressed up in bureaucratic language.
